|
|
|
|
|
|
Companies > Clinical
|
|
|
Great Lakes Pharmaceuticals is a specialty pharmaceutical company that is developing an anti-infective lock solution to address in-dwelling venous catheter mediated infection. The company acquired rights to unique technologies that inhibit formation of biofilms and eradicates established biofilm.
Funders:
Charter Life Sciences, Early Stage Partners, North Coast Angel Fund, Ohio Tech Angel Fund, Case Technology Ventures, JumpStart
|
|
|
|
|